The BIA Global Strategy Model Portfolio has added a 10% position in: IHE the iShares Dow Jones U.S. Pharmaceuticals Index ETF at a cost of 78.77.
The BIA Global Strategy Model Portfolio has added a 10% position in: IBB the iShares Nasdaq Biotechnology Index fund at a cost of 119.51.
DISCLAIMER: Nothing in this article should be construed as a personal recommendation or advice. Nor should anything in this article be construed as an offer, or a solicitation of an offer, to sell or buy any investment security.
The BIA Global Strategy Model Portfolio engages in short term aggressive, speculative strategies with an appropriate portion of an investor’s overall investable assets. Investors should conduct their own due diligence and seek the advice of a financial and/or investment professional before making any investment decisions